166 related articles for article (PubMed ID: 8287069)
1. Identification of specific intracellular domains of the human ETA receptor required for ligand binding and signal transduction.
Hashido K; Adachi M; Gamou T; Watanabe T; Furuichi Y; Miyamoto C
Cell Mol Biol Res; 1993; 39(1):3-12. PubMed ID: 8287069
[TBL] [Abstract][Full Text] [Related]
2. Ligand binding domain of the human endothelin-B subtype receptor.
Wada K; Hashido K; Terashima H; Adachi M; Fujii Y; Hiraoka O; Furuichi Y; Miyamoto C
Protein Expr Purif; 1995 Jun; 6(3):228-36. PubMed ID: 7663155
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the endothelin type A receptor (ETA): interactions and model of selective ETA antagonist BMS-182874 with putative ETA receptor binding cavity.
Webb ML; Patel PS; Rose PM; Liu EC; Stein PD; Barrish J; Lach DA; Stouch T; Fisher SM; Hadjilambris O; Lee H; Skwish S; Dickinson KE; Krystek SR
Biochemistry; 1996 Feb; 35(8):2548-56. PubMed ID: 8611558
[TBL] [Abstract][Full Text] [Related]
4. Truncation of the receptor carboxyl terminus impairs membrane signaling but not ligand binding of human ETB endothelin receptor.
Koshimizu T; Tsujimoto G; Ono K; Masaki T; Sakamoto A
Biochem Biophys Res Commun; 1995 Dec; 217(1):354-62. PubMed ID: 8526934
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
[TBL] [Abstract][Full Text] [Related]
6. Functional domains of human endothelin receptor.
Adachi M; Hashido K; Trzeciak A; Watanabe T; Furuichi Y; Miyamoto C
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S121-4. PubMed ID: 7509921
[TBL] [Abstract][Full Text] [Related]
7. Identification of ETA and ETB binding domains using ET-derived photoprobes.
Aubin J; Létourneau M; Francoeur E; Burgeon E; Fournier A
Biochimie; 2008 Jun; 90(6):918-29. PubMed ID: 18343229
[TBL] [Abstract][Full Text] [Related]
8. Subtype-specific sorting of the ETA endothelin receptor by a novel endocytic recycling signal for G protein-coupled receptors.
Paasche JD; Attramadal T; Kristiansen K; Oksvold MP; Johansen HK; Huitfeldt HS; Dahl SG; Attramadal H
Mol Pharmacol; 2005 May; 67(5):1581-90. PubMed ID: 15713850
[TBL] [Abstract][Full Text] [Related]
9. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
10. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
11. Functional role of the extracellular N-terminal domain of neuropeptide Y subfamily receptors in membrane integration and agonist-stimulated internalization.
Lindner D; Walther C; Tennemann A; Beck-Sickinger AG
Cell Signal; 2009 Jan; 21(1):61-8. PubMed ID: 18845246
[TBL] [Abstract][Full Text] [Related]
12. Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells.
Berry PA; Zhang YF; Carter ND; Jeffery S; Burchill SA
Med Pediatr Oncol; 2001 Jan; 36(1):142-6. PubMed ID: 11464869
[TBL] [Abstract][Full Text] [Related]
13. Endothelin stimulates sis-inducing factor-like DNA binding activity in CHO-K1 cells expressing ETA receptors.
Peeler TC; Conrad KM; Baker KM
Biochem Biophys Res Commun; 1996 Apr; 221(1):62-6. PubMed ID: 8660344
[TBL] [Abstract][Full Text] [Related]
14. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the receptors for axon guidance factor netrin-4 and identification of the binding domains.
Qin S; Yu L; Gao Y; Zhou R; Zhang C
Mol Cell Neurosci; 2007 Feb; 34(2):243-50. PubMed ID: 17174565
[TBL] [Abstract][Full Text] [Related]
16. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
Andrews G; Jones C; Wreggett KA
Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
[TBL] [Abstract][Full Text] [Related]
17. Identification of a ligand-binding site of the human endothelin-A receptor and specific regions required for ligand selectivity.
Adachi M; Furuichi Y; Miyamoto C
Eur J Biochem; 1994 Feb; 220(1):37-43. PubMed ID: 8119297
[TBL] [Abstract][Full Text] [Related]
18. Truncation of N-terminal extracellular or C-terminal intracellular domains of human ETA receptor abrogated the binding activity to ET-1.
Hashido K; Gamou T; Adachi M; Tabuchi H; Watanabe T; Furuichi Y; Miyamoto C
Biochem Biophys Res Commun; 1992 Sep; 187(3):1241-8. PubMed ID: 1417800
[TBL] [Abstract][Full Text] [Related]
19. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.
Belville C; Maréchal JD; Pennetier S; Carmillo P; Masgrau L; Messika-Zeitoun L; Galey J; Machado G; Treton D; Gonzalès J; Picard JY; Josso N; Cate RL; di Clemente N
Hum Mol Genet; 2009 Aug; 18(16):3002-13. PubMed ID: 19457927
[TBL] [Abstract][Full Text] [Related]
20. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
Park CG; Ganguli SC; Pinon DI; Hadac EM; Miller LJ
J Pharmacol Exp Ther; 2000 Nov; 295(2):682-8. PubMed ID: 11046106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
